Sugar-based Excipients Market Revenue, Demand, Opportunity, Segment and Key Trends

The Increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs, and increasing development of orally disintegrating tablets (ODTs) are expected to propel the growth of this market. However, stringent regulatory requirements leading to shortage of FDA-approved manufacturing sites can hinder their market growth to a certain extent.

The report “Sugar-Based Excipients Market by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners), Type (Powder/Granule, Crystal, Syrup), Functionality (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, Parenteral) – Global Forecast”, the sugar excipients market has witnessed healthy growth during the last decade, and is expected to grow at a CAGR of 4.3%, to reach USD 1,060.6 Million.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=242342136

Sugar-Based Excipients Market Segmentation in Detailed:

Based on type, segmented into powders/granules, direct compression sugars, crystals, and syrups.

on the basis of functionality, segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities.

Based on formulation, segmented into oral formulations, parenteral formulations, topical formulations, and other formulations.

Based on the type, segmented into powders/granules, direct compression sugars, crystals, and syrups. Similarly, on the basis of functionality, the market is segmented into fillers & diluents, flavoring agents, tonicity agents, and other functionalities

The actual sugar accounted for the largest share of the global sugar excipients market. The sugar alcohols segment is expected to witness the highest growth in the next five years primarily due to the rising use of mannitol in a wide range of dosage forms such as oral and topical, and its high adaptability in emerging formulation technologies, such as orally disintegrating tablets. On the basis of type, powders/granules segment accounted for the large share of the global Sugar-Based Excipients Market. The large share of the powders/granules segment is mainly attributed to its wide use in various types of formulations in the pharmaceutical industry.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242342136

Geographical View in-detailed:

Europe is the largest regional segment for the global sugar excipients market. The large share of this regional segment can be attributed to increasing investments in drug development, increasing production of generic drugs, and favorable government initiatives in the region. The market in the Asia-Pacific region is expected to register the highest CAGR owing to the significant growth in the regional healthcare market as well as the pharmaceutical industry, growing scientific base and capability, and favorable government policies, and low-cost manufacturing advantage in this region.

Global Key Leaders:

Roquette Group (France), DFE Pharma (Germany), BASF SE (Germany), and Ashland Inc. (U.S.), held the major share of the sugar excipients market, and are expected to dominate the market during the forecast period. Other major players in this market are Associated British Foods Plc (U.K.), Cargill, Inc. (U.S.), Colorcon, Inc. (U.S.), FMC Corporation (U.S.), MEGGLE AG (Germany), and The Lubrizol Corporation (U.S.).

Medical Decision Support Systems for Sepsis Market - Anticipated To Witness High Growth In The Near Future

The report “Medical Decision Support Systems for Sepsis Market Revolutionary Primer for Clinical Decision Support (Market Dynamics, Case Studies, Regional Analysis (North America, Europe, Asia Pacific, Rest of the World)) – Global Forecast to 2022″, The MDSS for Sepsis Market is expected to reach USD 35.6 Million, at a CAGR of 24.3%.

Increasing funding & research grants, growing pressure to curb healthcare spending, and improving patient outcomes are the major factors propelling the growth of the market. In addition, machine learning & artificial intelligence in CDSS is posing as a lucrative opportunity for the market in the coming years.

Various players in the market offer sepsis CDS solutions embedded in their EHR while there are others who offer separate surveillance solutions for sepsis.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227232851

Objectives of the Study:

– To define, describe, and forecast the global medical decision support systems for sepsis market on the basis of region

– To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)

– To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market

– To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

– To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World

Geographically, the North American market accounted for the largest share in 2017 and is expected to register the highest CAGR during the forecast period. The large share and high growth can be attributed to factors such as increasing efforts to curb healthcare spending, federal initiatives such as the Hospital Readmissions Reduction Program, and rising investments in HCIT solutions in the country. Major players providing sepsis CDS modules include Cerner, Epic, and MEDITECH. Third-party vendors like VigiLanz, Iatric Systems, and PeraHealth are also based out of the US. The presence of these key players in the country has made the US a center of innovation in the CDSS market. Moreover, growing awareness regarding the use of HCIT solutions for sepsis management, high number of installations of CDS solutions, and various studies have been conducted to check benchmark for the efficacy of different solutions in the US.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227232851

Global Key Leaders:

Wolters Kluwer Health (US), Cerner Corporation (US), Philips Healthcare (Netherlands), Amara Health Analytics (US), McKesson Corporation (US), Ambient Clinical Analytics (US), Iatric Systems Inc. (US), PeraHealth Inc. (US), Health Catalyst Inc. (US), and Allscripts Healthcare Solutions, Inc. (US) are the key players in the global medical decision support systems for sepsis market.

Bone Cement Market Analysis, Segments, Key Players, Drivers, Trends and Forecast

The report “Bone Cement and Glue Market by Type (PMMA, Calcium Phosphate, Natural, Synthetic), Application (Arthroplasty (Total Knee, Hip, Shoulder), Kyphoplasty, Vertebroplasty), End User (Hospitals, Clinics, Ambulatory Surgery Centers) – Global Forecast to 2022″, the bone cement market is expected to reach USD 1,322.6 Million, at a CAGR of 5.9%

The Factors driving the growth of this market include growing geraitic population, increasing incidence of sports injuries, rising number of road accidents, and increasing developments in the regenerative medicines field.

The objectives of this study are as follows:

• To define, describe, segment, and forecast the market by type, application, end user, and region
• To forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To identify micro-markets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=131540876

Bone cement is estimated to account for the largest market share

On the basis of type, Classified into bone cement and bone glue. The bone cement segment is expected to lead the global bone cement and glue market in 2017. Factors driving the growth of this segment include rising incidence of osteoporosis and increasing number of arthroplasty procedures across the globe.

The arthroplasty segment is estimated to dominate the market

By application, the market is segmented into arthroplasty, kyphoplasty, vertebroplasty, and other applications. The arthroplasty segment is anticipated to account for the largest share of the global bone cement and glue market in 2017. The large share of this segment can be attributed to the increasing number of knee, hip, and shoulder injuries.

The hospital segment is estimated to command the largest share of the market during the forecast period

On the basis of end user, Categorized into hospitals, ambulatory surgery centers (ASCs), and clinics/physician offices. The hospitals segment is estimated to account for the largest share of the global bone glue market. The heavy burden of orthopaedic medical conditions (which requires implants for their management) and increasing number of hospitals are the key factors driving the growth of this end-user segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=131540876

Geographically; the bone cement market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is estimated to dominate the market in 2017. This is attributed to factors such as the increasing incidence of sports injuries, growing geriatric population, and improved healthcare infrastructure in the region.

Key players in the bone cement and glue market include Stryker (US), Zimmer Biomet (US), DePuy Synthes (US), Smith & Nephew (UK), Arthrex (US), DJO Global (US), Exactech (US), TEKNIMED (France), Heraeus Medical (Germany), CryoLife (US), Cardinal Health (US), and Trimph (Australia).

Global Dental Syringes Market Trends and Industry Analysis Report 2020

The Technological advancements in dental syringes, growth in geriatric population and government legislations to avoid needlestick injuries are adding to the growth prospects of this market.

Emerging markets (such as India, China, Brazil, and Mexico) offer significant growth opportunities for players operating in the dental syringes market. The growth of the market in these regions can be attributed to factors such as rising geriatric population, rising awareness among healthcare professionals related to needlestick injuries, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Expected Revenue Surge: The Dental Syringes Market is expected to reach USD 126.9 Million, at a CAGR of 5.2% during the forecast period

Objectives of the Study;

• To define, describe, and forecast the global market on the basis of product, type, material, and region
• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global market
• To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42523876

Market Segmentation in Detailed:

Based on Product;

Categorized into three segments, namely, non-disposable syringes, disposable syringes, and safety syringes. The non-disposable syringes segment is expected to dominate the dental syringes market in 2016 mainly due to the growing number of endodontic & periodontic procedures across the globe, significant adoption of non-disposable syringes among dental professionals for administering anesthesia, and greater affordability of these products due to their reusable nature.

Based on Type,

Segmented into two segments, namely, aspirating syringes, and non-aspirating syringes. The aspirating syringes segment is expected to dominate the dental syringes market during the forecast period. The prominent market position of the aspirating syringes segment can be primarily attributed to the procedural benefits offered by aspirating syringes over conventional syringes (such as easy syringe handling, minimal operational stress, and better operational control), and longer shelf life of metallic syringes (as compared to conventional plastic syringes).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42523876

Geographically;

Segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to needlestick injuries, ongoing government initiatives to modernize & expand healthcare infrastructure, and continuous reduction in product prices.

Global Key Leaders:

Septodont (U.S.), 3M Company (U.S.), Dentsply International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Vista Dental Products (U.S.), Power Dental USA, Inc. (U.S.), 4tek S.r.l (Italy), A. Titan Instrument Inc. (U.S.), and Delmaks Surgico (Pakistan) were some of the key players operating in the dental syringes market.

Cardiac Mapping Market - Segmentation, Geographical Analysis & Major Key Players

The report “Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region – Global Forecast to 2024″, the Cardiac Mapping System Market is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.

The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.

Market Size Estimation;

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac mapping market. These methods were also used extensively to determine the extent of various subsegments in the market. The research methodology used to estimate the market size includes the following:

– The key players in the industry and markets have been identified through extensive secondary research

– The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

– All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405

Atrial fibrillation is the primary application areas of the global cardiac mapping market

The market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment estimated to command the largest share of the market in 2019, and this segment is also projected to register the highest CAGR owing to the rise in incidences of AF worldwide and the subsequent increase in the ablation procedures.

Geographical View in-detailed:

North America held the largest share of the market in 2019 and is projected to continue to do so during the forecast period. Factors such as the increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, growing focus of government organizations on providing funding for research, and increasing geriatric population in Canada are driving the North American cardiac mapping market.

Key Market Players;

The major vendors in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence. The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405

Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018. The large share of this company can be attributed to its strong suite of cardiac mapping systems, software, and catheters. The company provides products mainly targeted at the diagnosis and treatment of several cardiac arrhythmias, such as atrial fibrillation. Moreover, the firm has a strong geographic presence in all regions of the world. The company focuses on product launches to create a strong foothold in the market. In 2019, Biosense introduced the CARTONET, a cloud-based networking and data analytics software solution.

Abbott (US) held the second-largest share of the cardiac mapping market in 2018. The company offers an advanced EnSite Precision cardiac mapping system, along with sensor-enabled catheters compatible with the mapping system. The firm’s Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases. The firm focuses on organic & inorganic growth strategies.

Gynecology Surgical Instrument Market | Business Overview, Products and Services, Key Insights, Recent Developments

The report “Gynecology Surgical Instruments Market by Product (Scissors, Forceps, Trocar, SIMS, CUSCO), Application (Laparoscopy, Colposcopy, Hysteroscopy, D&C, Ablation, Biopsy), & End User (Hospital, Clinic, Ambulatory Surgery Center) – Global Forecast”, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and Rest of the World (RoW).

The Gynecology Surgical Instruments Market is expected to reach USD 2.44 Billion, at a CAGR of 7.1%

The market is mainly driven by factors such as high incidence of gynecological diseases, increasing awareness programs, and rising government investments for providing advanced healthcare facilities & services, increasing disposable income in developing countries, and rising incidence of lifestyle disorders.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=122824797

Market Segmentation in Detailed:

On the basis of products, segmented into forceps, scissors, needle holders, dilators, trocars, vaginal speculums, and other instruments. Forceps are expected to account for the largest share of the market, in 2016. The growth of the forceps segment is attributed to the increase in the number of gynecological surgeries and the repeated use of forceps in most gynecological surgeries.

Based on application, the Gynecology Surgical Instruments Market is further segmented into laparoscopy, hysteroscopy, dilation and curettage, colposcopy, and other applications. Laparoscopy segment is expected to grow at the highest CAGR during the forecast period. Laparoscopy forms the largest and fastest-growing application segment of the market. This is mainly attributed to the various advantages of laparoscopy procedures, which includes less blood loss, shorter hospital stays, and fewer intraoperative & postoperative complications.

On the basis of end user, categorized into hospitals, clinics, and ambulatory surgery centers. In 2016, hospitals and clinics were expected to be the major end-user segment in the market. The large share of this segment can be attributed to the increasing incidence of gynecological diseases and the need for timely diagnosis and treatment of these diseases, growing government involvement in increasing awareness regarding women’s health issues, and increase in funding and infrastructural development in hospitals.

Geographical View in-detailed:

The global gynecology surgical instrument market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The market in Asia is expected to grow at the highest CAGR during the forecast period. Factors such as increasing awareness programs, high incidence of gynecological diseases, increasing number of hospitals, government initiatives focusing on women’s health, and improvements in the healthcare sector of Asian countries contribute to the growth of the market in Asia.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122824797

Global Key Leaders:

The Gynecology Surgical Instruments Market is highly fragmented with several big and emerging players. Key market players include B. Braun Melsungen AG (Germany), CooperSurgical Inc. (U.S.), Ethicon, Inc. (U.S.), KARL STORZ GmbH & Co. KG (Germany), KLS Martin Group (U.S.), MedGyn Products (U.S.), Olympus Corporation (Japan), Richard WOLF GmbH (Germany), Sklar Surgical Instruments (U.S.), and Tetra Surgical (Pakistan).

Molecular Cytogenetics Market Professional Survey Report 2019

The report “Molecular Cytogenetics Market by Product (Kit, Reagent, Probe, Consumable, Software, Service), Technique (In-Situ, FISH, Comparative Genomic Hybridization), Application (Cancer, Genetic), End User (Research Labs, Institutes) – Forecast “, the research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the market along with the estimates and forecasts of the revenue and market share analysis.

The molecular cytogenetics market is projected to reach USD 2.52 Billion, at a CAGR of 10.1%

The high incidence and large economic burden of genetic disorders and cancer and rise in healthcare expenditure has resulted in the increasing use of molecular cytogenetic products in clinical and research laboratories, academic research institutes, and pharmaceutical and biotechnology companies.

Major Market Developments;

– In January 2014, Roche acquired Genia Technologies, Inc. (U.S.). This acquisition strengthened Roche’s Next Generation Sequencing pipeline.

– In February 2015, Roche acquired Signature Diagnostics AG (Germany).

– In January 2016, Thermo Fisher Scientific, Inc. acquired Affymetrix (U.S.). This acquisition strengthened Thermo Fisher Scientific’s leadership into bioscience business and create new market opportunities in genetic analysis.

– In July 2016, Thermo Fisher Scientific and HEALTH BioMed (China) collaborated to support HBM’s development of molecular diagnostic kits for infectious diseases and pharmacogenomics screening which will serve the Chinese market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=148469224

Market Segmentation in Detailed:

On the basis of techniques, segmented into comparative genomic hybridization, fluorescence in situ hybridization, in situ hybridization, and other techniques.

Based on applications, the molecular cytogenetics market is segmented into genetic disorders, cancer, personalized medicine, and other applications. The genetic disorders segment is expected to account for the largest share of the global market.

Based on end users, segmented into clinical and research laboratories, academic research institutes, pharmaceutical and biotechnology companies, and others. The clinical and research laboratories segment is expected to account for the largest share of the global molecular cytogenetics market in 2016. Rise in healthcare expenditure has resulted in the increasing diagnosis of genetic disorder and cancer resulting in increasing use of cytogenetic kits and reagents in the above mentioned end users.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148469224

Geographical View in-detailed:

The global molecular cytogenetics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in the aging population and increasing prevalence of cancer and genetic disorders in the region.

Global Key Leaders:

Key players in the molecular cytogenetics market include F. Hoffmann-La Roche Ltd. (Switzerland) Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Gene Technology (U.K.), and Applied Spectral Imaging (U.S.).

Embolic Protection Devices Market 2021 - Segments, Trends, Share and Forecast Growth

The Research Report on“Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane), Application (Cardiovascular, Neurovascular, Peripheral), Indication (PCI, SVD, TAVR) – Global Forecast to 2023″ published by MarketsandMarkets™, is projected to reach USD 604.9 Million, at a CAGR of 8.3% during the forecast period.

The growth in this market is mainly attributed to factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures.

Research Methodology;

Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource, journals and their market revenues were determined through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with the key opinion leaders such as CEOs, directors, and marketing executives. The percentage splits, shares, and breakdowns of the product markets were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=158143803

Embolic Protection Devices Market Segmentation in Detailed:

The neurovascular segment is expected to grow at the highest CAGR during the forecast period

On the basis of application, categorized into cardiovascular, neurovascular, and peripheral vascular diseases. The neurovascular segment is expected to grow at the highest CAGR during the forecast period. The favorable medical reimbursement scenarios for neurovascular procedures in developed countries, increasing awareness about the clinical efficacy of embolic protection devices among neurosurgeons, and the rising adoption of these systems across developing countries (such as China and India) are expected to drive the growth of this application segment during the forecast period.

The percutaneous coronary intervention segment accounted for the largest market share in 2017

On the basis of indication, categorized into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. In 2017, the percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures.

Geographical View in-detailed:

North America dominated the embolic protection devices market. The rising geriatric population and prevalence of cardiovascular and neurovascular diseases, increasing adoption of minimally invasive techniques, increasing availability of funding, and the presence of a large number of medical device product manufacturers are driving the growth of the market in North America. However, the APAC is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the growing geriatric population, rising prevalence of CVD, increasing number of facilities, and rising healthcare expenditure.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158143803

Global Key Leaders:

The prominent players in the embolic protection devices market are Boston Scientific (US), Medtronic  (Ireland), Abbott (US), Cordis (A Cardinal Health Company) (US), Allium Medical (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and AngioSlide (Israel).

Cell Harvesting Market - Emerging Industry Trends and Global Future Forecast

The report “Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) – Global Forecast”, the cell harvesters market is expected to reach USD 324.5 Million, at a CAGR of 8.7%

The Cell harvesting is the process of harvesting cells from the culture media during upstream and downstream bio-processing. Cell harvesters are used extensively for the cell harvesting process and are compatible with a wide range of assays. Rising investments in regenerative medicine and cell-based research, growth of the biotechnology and bio-pharmaceutical industry, and increasing incidence of chronic and infectious diseases are the major factors that are driving the growth of this market.

The objectives of this study are as follows:

• To define, describe, and forecast the cell harvesting market for cell harvesting, on the basis of type, application, end user, and region
• To provide detailed information regarding the major factors influencing growth of the market (drivers, opportunities, and restrains)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=209513544

The manual cell harvesters segment dominated the market.

On the basis of type, the market is segmented into manual and automated cell harvesters. In 2017, the manual cell harvesters segment accounted for the largest share of this market. The high share of the manual harvesters segment can be attributed to their ease of use and low price as compared to automated harvesters.

The biotechnology & biopharmaceutical companies segment dominated the market.

In the end user, the cell harvesting market is segmented into research institutes, biotechnology & biopharmaceutical companies, and other end users. In 2017, the biotechnology & biopharmaceutical companies segment accounted for the largest share of the cell harvesters market. The high share of this segment can be attributed to the high prevalence of chronic diseases. Biotechnology & biopharmaceutical companies conduct R&D activities to develop new products for the treatment of these diseases.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209513544

Geographical View in-detailed:

The global cell harvesting market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). While North America held the largest share of the market in 2017, Asia Pacific is expected to register the highest CAGR during the forecast period. As increasing R&D expenditure helps in the development of new treatment solutions, supportive government policies for stem cell research and increasing public-private initiatives to encourage public adoption of stem cell-based treatment in the Asia Pacific countries are driving the growth of the market in this region.

Global Key Leaders:

Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).